Adis Journals
Browse

Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults

Download (587.19 kB)
media
posted on 2022-05-20, 11:00 authored by Adis journals on behalf of, Lida Teng, Akiko Mizukami, Cheryl Ng, Nikolaos Giannelos, Desmond Curran, Tomohide Sato, Christa Lee, Taizo Matsuki
<p>The above graphical PLS represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). </p> <p>© The authors, CC-BY-NC 2022. </p>

History

Related Materials

  1. 1.
    URL - References https://link.springer.com/article/10.1007/s13555-022-00744-8
  2. 2.
    DOI - Is supplement to Cost-Effectiveness Analysis Update of the Adjuvanted Recombinant Zoster Vaccine in Japanese Older Adults

Usage metrics

    Dermatology and Therapy

    Categories

    Keywords

    Cost-effectivenessHerpes zosterIncremental cost-effectiveness ratioMarkov model.Older AdultsPostherpetic neuralgiaQuality-adjusted life yearsRecombinant zoster vaccineShinglesVaccinationGraphical PLS

    Licence

    CC BY-NC 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC